Exhibit 107
Calculation of Filing Fee Tables
S-3
(Form Type)
Summit Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title (1) | Fee Calculation Rate | Amount Registered | Proposed Maximum Offering Price Per Security (2) | Maximum Aggregate Offering Price(2) | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||
| Fees to be paid | Equity | Common Stock, par value $0.01 per share | 457 | (c) | 19,720,291 | $ | 1.42 | $ | 28,002,813.22 | 0.00011020 | $ | 3,085.91 | ||||||||||||||||
| Fees previously paid | ||||||||||||||||||||||||||||
| Total Offering Amounts | $ | 28,002,813.22 | $ | 3,085.91 | ||||||||||||||||||||||||
| Fees Previously Paid | $ | 0.00 | ||||||||||||||||||||||||||
| Net Fees Due | ||||||||||||||||||||||||||||
| $ | 3,085.91 | |||||||||||||||||||||||||||
| (1) | The shares of common stock will be offered for resale by the selling stockholders pursuant to the prospectus contained in the registration statement to which this exhibit is attached. The registration statement registers the resale of an aggregate of 19,720,291 shares of the Registrant’s common stock. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events. |
| (2) | Estimated in accordance with Rule 457(c) solely for the purpose of calculating the total registration fee on the basis of $1.42 per share, which represents the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Global Market on March 10, 2023. |
